Table 3 Recurrence free survival – stratified models.

From: Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer

Strata

IGHM

HR

IGHM

p value

IGHA2

HR

IGHA2

p value

IGJ

HR

IGJ

p value

IGHG1

HR

IGHG1

p value

Age

0.70

0.43–1.16

0.168

0.60

0.38–0.94

0.026

0.53

0.33–0.85

0.009

1.04

0.64–1.71

0.868

Node status

0.61

0.37–1.00

0.052

0.57

0.37–0.88

0.012

0.47

0.30–0.76

0.002

0.94

0.58–1.54

0.819

Size

0.71

0.46–1.10

0.128

0.66

0.44–0.99

0.043

0.58

0.38–0.89

0.012

1.04

0.66–1.62

0.875

ER status

0.59

0.37–0.94

0.027

0.59

0.39–0.90

0.013

0.50

0.33–0.77

0.002

0.91

0.56–1.49

0.720

HER2 status

0.67

0.42–1.06

0.085

0.62

0.41–0.94

0.023

0.54

0.35–0.83

0.005

1.08

0.68–1.73

0.741

Grade

0.66

0.43–1.01

0.054

0.70

0.46–1.07

0.098

0.56

0.37–0.85

0.006

0.82

0.53–1.26

0.370

  1. Univariable Cox proportional hazards models of the cohort270 with recurrence-free survival as end point. The modeling was done with the normalized log2 of the expression of indicated Ig mRNA and each model was stratified for variable indicated in the rightmost column. Data indicate hazard ratios with 95% confidence intervals (italics) and p values.